Moving averages are one of the core indicators in technical analysis. A Simple Moving Average (SMA) is simply the arithmetic average of stock price over a period. It is calculated by adding a selected range of prices, usually closing prices, and then dividing that figure by the number of time periods in that range.
The 50-Day SMA calculates the average price over 50 days. And the 20-Day SMA and 200-Day SMA calculates the average price over 20 days and 200 days separately.
As of today (2024-05-04), Merge Healthcare's 50-Day SMA is €N/A. It's 20-Day SMA is €N/A and 200-Day SMA is €N/A.
Competitive Comparison of Merge Healthcare's 50-Day SMA
For the Health Information Services subindustry, Merge Healthcare's 50-Day SMA, along with its competitors' market caps and 50-Day SMA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merge Healthcare's 50-Day SMA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Merge Healthcare's 50-Day SMA distribution charts can be found below:
* The bar in red indicates where Merge Healthcare's 50-Day SMA falls into.
Merge Healthcare (FRA:MRJ) 50-Day SMA Calculation
The formula for calculating SMA is:
SMA
=
( P1 + P2 + ... + Pn )
/
n
where:
Pn is the price of the stock at period n.
n is the total number of periods.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merge Healthcare (FRA:MRJ) 50-Day SMA Explanation
Simple Moving Average (SMA) is the arithmetic average of stock price over a period. The 20-Day SMA calculates the average price over 20 days. And the 50-Day SMA and 200-Day SMA calculates the average price over 50 days and 200 days separately. SMAs are often used to determine the price trend direction. A 200-Day SMA is usually a proxy for the long-term trend, while shorter periods indicate short-term trend.
SMA are commonly compared with stock price or different period SMAs to indicate a trading signal. Generally speaking, if the price goes above the SMA, or a short-term SMA crosses above a long-term SMA, an uptrend is expected, investors may want to go long or cover short. Conversely, if the price goes below the SMA, or the short-term SMA crosses below a long-term SMA, a downtrend is expected, investors may want to go short or exit long.
Two popular trading patterns that use SMA include the death cross and a golden cross. A death cross occurs when the 50-day SMA crosses below the 200-day SMA. This is considered a bearish signal, that further losses are in store. The golden cross is a bullish signal which occurs when a short-term SMA crosses above a long-term SMA.
Merge Healthcare 50-Day SMA Related Terms
Thank you for viewing the detailed overview of Merge Healthcare's 50-Day SMA provided by GuruFocus.com. Please click on the following links to see related term pages.
Merge Healthcare Inc is a Delaware corporation founded in 1987. The Company develops enterprise imaging software solutions that facilitate the management of images to create a more effective and efficient electronic healthcare experience for patients and physicians. Its solutions are designed to help solve some of the difficult challenges in health information exchange today, such as the incorporation of medical images and diagnostic information into broader healthcare IT applications, the interoperability of proprietary software solutions, and the ability to improve the efficiency and cost effectiveness of its customers businesses. The Companys solutions optimize processes for healthcare providers ranging in size from single provider practices to large health systems, to the sponsors of clinical trials and medical device manufacturers. It operates in two reportable segments: Merge Healthcare mainly generates revenue from the sale of software including upgrades; hardware, professional services, maintenance and electronic data interchange services. Merge DNA derives the vast majority of its revenue from software, professional services and hosting through subscription arrangements. Its product portfolio provides products and services to its customers, including Image Interoperability Platform iConnect: This interoperability and connectivity platform enables hospitals, imaging centers, Integrated Delivery Networks and Health Information Exchanges to create information exchanges within their environments and with other entities.,Clinical and Financial Information Systems - Digital Imaging Solutions: Picture Archiving and Communication Systems, specialty workstations and related applications manage the image workflow of a medical enterprise; Clinical information systems: These systems provide a complete electronic record of a medical procedure across a variety of specialties including Merge OrthoEMR for orthopaedics, and Merge RIS for radiology; Revenue Cycle Management: It offer software and services for the revenue cycle management of physician practices, Software Development Toolkits, Technologies and Platforms - Merge toolkits, technologies and platforms provide software developers with the necessary resources to assist in the timely development of new products and enhance existing products and Hosted Software Solutions for Clinical Trial Data Management It provide hosted software solutions for the collection, aggregation, analysis, reporting and overall management of clinical trials information. Its strategy is to be a provider of integrated, healthcare IT solutions and services that improve the exchange of healthcare information. It is subject to regulation in the U.S. by the Food and Drug Administration, including periodic FDA inspections, in Canada under Health Canadas Medical Devices Regulations, and in other countries by corresponding regulatory authorities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:MRJ has been successfully added to your